← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Trevena, Inc.
King Of Prussia, PA
$7,977,805
Total funding
2
Grants
Funding over time
peak $4.2M · FY2009–13$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$7,977,805 · 2
By mechanism
RC2$7,639,642 · 1
U01$338,163 · 1
Investigators at Trevena, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Selective modulation of GPCR signal transduction with biased ligands$4,214,058
RC2 · FY2009 · MH
Selective modulation of GPCR signal transduction with biased ligands$3,425,584
RC2 · FY2010 · MH
A novel delta opioid receptor biased agonist for Major Depressive Disorder$154,370
U01 · FY2012 · NS
A novel delta opioid receptor biased agonist for Major Depressive Disorder$154,370
U01 · FY2011 · NS
A novel delta opioid receptor biased agonist for Major Depressive Disorder$29,422
U01 · FY2012 · NS
A novel delta opioid receptor biased agonist for Major Depressive Disorder$1
U01 · FY2013 · NS